Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term General disorders and administration site conditions
ADR ID BADD_A01804
ADR Hierarchy
08      General disorders and administration site conditions
Description Not Available
MedDRA Code 10018065
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00544Cyclo-upup--
BADD_D00545Cyclobenzaprine0.000441%
BADD_D00546Cyclobenzaprine hydrochloride--
BADD_D00547Cyclopentolate0.013385%
BADD_D00548Cyclopentolate hydrochloride--
BADD_D00549Cyclophosphamide--
BADD_D00550Cycloserine--
BADD_D00551Cyclosporine0.073610%
BADD_D00552Cyproheptadine--
BADD_D00553Cyproheptadine hydrochloride--
BADD_D00554Cyproterone--
BADD_D00555Cyproterone acetate--
BADD_D00556Cysteamine0.007633%
BADD_D00557Cysteamine bitartrate--
BADD_D00559Cysteine hydrochloride--
BADD_D00560Cytarabine0.019140%
BADD_D00561Cytarabine hydrochloride--
BADD_D00562Cytomegalovirus immune globulin (human)--
BADD_D00563Dabigatran0.063831%
BADD_D00564Dabigatran etexilate--
BADD_D00565Dabigatran etexilate mesylate--
BADD_D00566Dabrafenib0.041201%
BADD_D00567Dabrafenib mesylate--
BADD_D00568Dacarbazine0.001533%
BADD_D00569Daclatasvir dihydrochloride--
BADD_D00570Daclizumab--
BADD_D00571Dactinomycin0.000616%
BADD_D00572Dalbavancin--
BADD_D00573Dalbavancin hydrochloride--
BADD_D00574Dalfampridine1.224740%
The 18th Page    First    Pre   18 19 20 21 22    Next   Last    Total 82 Pages